

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | gamma-aminobutyric acid transport (GO:0015812) | 6.58745048 |
| 2 | positive regulation of mitochondrial fission (GO:0090141) | 4.98556039 |
| 3 | startle response (GO:0001964) | 4.40461709 |
| 4 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.38324163 |
| 5 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.34208487 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.33153306 |
| 7 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.21911731 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.16928352 |
| 9 | synaptic transmission, glutamatergic (GO:0035249) | 4.08366310 |
| 10 | neuronal action potential propagation (GO:0019227) | 4.05279574 |
| 11 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.84464972 |
| 12 | neurotransmitter secretion (GO:0007269) | 3.74141424 |
| 13 | regulation of synaptic vesicle transport (GO:1902803) | 3.72617731 |
| 14 | neuron-neuron synaptic transmission (GO:0007270) | 3.72561311 |
| 15 | nucleobase catabolic process (GO:0046113) | 3.71015947 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.69942191 |
| 17 | glutamate secretion (GO:0014047) | 3.67609276 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 3.61687144 |
| 19 | regulation of hexokinase activity (GO:1903299) | 3.58175848 |
| 20 | regulation of glucokinase activity (GO:0033131) | 3.58175848 |
| 21 | regulation of mitochondrial fission (GO:0090140) | 3.54219513 |
| 22 | response to pheromone (GO:0019236) | 3.49774676 |
| 23 | dopamine transport (GO:0015872) | 3.49350268 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.44873787 |
| 25 | protein localization to cilium (GO:0061512) | 3.44645174 |
| 26 | retinal cone cell development (GO:0046549) | 3.41887013 |
| 27 | glycerophospholipid catabolic process (GO:0046475) | 3.40750285 |
| 28 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.39648942 |
| 29 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.36544740 |
| 30 | glutamate receptor signaling pathway (GO:0007215) | 3.29213793 |
| 31 | protein localization to synapse (GO:0035418) | 3.24313768 |
| 32 | regulation of neurotransmitter levels (GO:0001505) | 3.22580290 |
| 33 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.18376132 |
| 34 | membrane depolarization during action potential (GO:0086010) | 3.16347631 |
| 35 | postsynaptic membrane organization (GO:0001941) | 3.14157122 |
| 36 | fucose catabolic process (GO:0019317) | 3.11108643 |
| 37 | L-fucose metabolic process (GO:0042354) | 3.11108643 |
| 38 | L-fucose catabolic process (GO:0042355) | 3.11108643 |
| 39 | neurotransmitter uptake (GO:0001504) | 3.09567315 |
| 40 | neuronal action potential (GO:0019228) | 3.08227363 |
| 41 | presynaptic membrane assembly (GO:0097105) | 3.06593967 |
| 42 | neurotransmitter transport (GO:0006836) | 3.05890848 |
| 43 | auditory behavior (GO:0031223) | 3.05664258 |
| 44 | transmission of nerve impulse (GO:0019226) | 3.03436344 |
| 45 | establishment of protein localization to Golgi (GO:0072600) | 3.03180365 |
| 46 | regulation of cilium movement (GO:0003352) | 3.02159101 |
| 47 | protein polyglutamylation (GO:0018095) | 2.99622878 |
| 48 | righting reflex (GO:0060013) | 2.99177209 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 2.94740252 |
| 50 | regulation of vesicle fusion (GO:0031338) | 2.94254962 |
| 51 | protein targeting to Golgi (GO:0000042) | 2.93083593 |
| 52 | detection of light stimulus involved in visual perception (GO:0050908) | 2.92672721 |
| 53 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.92672721 |
| 54 | vocalization behavior (GO:0071625) | 2.92244912 |
| 55 | behavioral response to nicotine (GO:0035095) | 2.89813584 |
| 56 | presynaptic membrane organization (GO:0097090) | 2.88645517 |
| 57 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.87626211 |
| 58 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.85862456 |
| 59 | synaptic vesicle endocytosis (GO:0048488) | 2.85557072 |
| 60 | glycosphingolipid biosynthetic process (GO:0006688) | 2.85412127 |
| 61 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.84588410 |
| 62 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.81439212 |
| 63 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.80307257 |
| 64 | C4-dicarboxylate transport (GO:0015740) | 2.79698838 |
| 65 | behavioral response to ethanol (GO:0048149) | 2.79098019 |
| 66 | regulation of synapse structural plasticity (GO:0051823) | 2.78905108 |
| 67 | axoneme assembly (GO:0035082) | 2.77590539 |
| 68 | protein-cofactor linkage (GO:0018065) | 2.76850894 |
| 69 | piRNA metabolic process (GO:0034587) | 2.76421914 |
| 70 | reflex (GO:0060004) | 2.75411908 |
| 71 | synapse assembly (GO:0007416) | 2.73763993 |
| 72 | mechanosensory behavior (GO:0007638) | 2.73540454 |
| 73 | regulation of feeding behavior (GO:0060259) | 2.71416403 |
| 74 | protein localization to Golgi apparatus (GO:0034067) | 2.69909762 |
| 75 | dendritic spine morphogenesis (GO:0060997) | 2.69114883 |
| 76 | catecholamine transport (GO:0051937) | 2.68991068 |
| 77 | establishment of synaptic vesicle localization (GO:0097480) | 2.67511729 |
| 78 | synaptic vesicle transport (GO:0048489) | 2.67511729 |
| 79 | establishment of mitochondrion localization (GO:0051654) | 2.66667826 |
| 80 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.63809515 |
| 81 | regulation of action potential (GO:0098900) | 2.63102243 |
| 82 | ketone body metabolic process (GO:1902224) | 2.62570448 |
| 83 | synaptic transmission (GO:0007268) | 2.62114847 |
| 84 | neuromuscular process controlling posture (GO:0050884) | 2.60648664 |
| 85 | axonal fasciculation (GO:0007413) | 2.60579809 |
| 86 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.58847737 |
| 87 | adult walking behavior (GO:0007628) | 2.58738022 |
| 88 | detection of calcium ion (GO:0005513) | 2.58652521 |
| 89 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.58051992 |
| 90 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.58051992 |
| 91 | pyrimidine dimer repair (GO:0006290) | 2.57491816 |
| 92 | rRNA catabolic process (GO:0016075) | 2.56973286 |
| 93 | establishment of vesicle localization (GO:0051650) | 2.56868320 |
| 94 | proline transport (GO:0015824) | 2.56118139 |
| 95 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.54644757 |
| 96 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.54357231 |
| 97 | neuron recognition (GO:0008038) | 2.51496416 |
| 98 | glycine transport (GO:0015816) | 2.50682998 |
| 99 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.49767107 |
| 100 | positive regulation of amino acid transport (GO:0051957) | 2.49302936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.81127569 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.77520198 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.54950139 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.14028595 |
| 5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.83461707 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.82460201 |
| 7 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.79544665 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.77374354 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.52810658 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.37927197 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.34971984 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.13269853 |
| 13 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.13156490 |
| 14 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.02342349 |
| 15 | FUS_26573619_Chip-Seq_HEK293_Human | 2.00041241 |
| 16 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.90423481 |
| 17 | P300_19829295_ChIP-Seq_ESCs_Human | 1.85723606 |
| 18 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.85471500 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.83906476 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.81992001 |
| 21 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75668258 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.69778429 |
| 23 | STAT3_23295773_ChIP-Seq_U87_Human | 1.68329710 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.68144646 |
| 25 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.67777200 |
| 26 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.67382679 |
| 27 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.67382679 |
| 28 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.64526846 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 1.63519353 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62081717 |
| 31 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.60606344 |
| 32 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.59270393 |
| 33 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.56718938 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55933340 |
| 35 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.53783619 |
| 36 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.53242922 |
| 37 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.51463182 |
| 38 | AR_25329375_ChIP-Seq_VCAP_Human | 1.50561226 |
| 39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50378105 |
| 40 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.49786922 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.48513712 |
| 42 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.47743817 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46217872 |
| 44 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.44768499 |
| 45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44113889 |
| 46 | TCF4_23295773_ChIP-Seq_U87_Human | 1.41268068 |
| 47 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.40917231 |
| 48 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.39010275 |
| 49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37645106 |
| 50 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.36829645 |
| 51 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.35485781 |
| 52 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.31736917 |
| 53 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.29922915 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29201463 |
| 55 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.27653440 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27565644 |
| 57 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.26107909 |
| 58 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.23881337 |
| 59 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.21634355 |
| 60 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.21356232 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20960606 |
| 62 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20844374 |
| 63 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20648972 |
| 64 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19668667 |
| 65 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19035085 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18150182 |
| 67 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.17098577 |
| 68 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.16606837 |
| 69 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.16606837 |
| 70 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16432775 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15008697 |
| 72 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.14338266 |
| 73 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.14136737 |
| 74 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13774346 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13120948 |
| 76 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.12424561 |
| 77 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12064617 |
| 78 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.11899607 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11452772 |
| 80 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10011303 |
| 81 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.09041016 |
| 82 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.09013320 |
| 83 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.07334491 |
| 84 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.07210125 |
| 85 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06024074 |
| 86 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.05746226 |
| 87 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.05565105 |
| 88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05137201 |
| 89 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04815350 |
| 90 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04794042 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04396893 |
| 92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.04231864 |
| 93 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.03461027 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02706409 |
| 95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02071555 |
| 96 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02071555 |
| 97 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01085549 |
| 98 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99996326 |
| 99 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99510720 |
| 100 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99347363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.76602772 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.30204998 |
| 3 | MP0003787_abnormal_imprinting | 3.08552596 |
| 4 | MP0009745_abnormal_behavioral_response | 3.08265566 |
| 5 | MP0009046_muscle_twitch | 2.97972705 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 2.82056127 |
| 7 | MP0008877_abnormal_DNA_methylation | 2.76671090 |
| 8 | MP0002272_abnormal_nervous_system | 2.66274329 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.62968581 |
| 10 | MP0004270_analgesia | 2.62138267 |
| 11 | MP0002064_seizures | 2.57628557 |
| 12 | MP0002102_abnormal_ear_morphology | 2.54199359 |
| 13 | MP0001486_abnormal_startle_reflex | 2.40512434 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.39932850 |
| 15 | MP0002822_catalepsy | 2.36161153 |
| 16 | MP0002063_abnormal_learning/memory/cond | 2.32355156 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.22122413 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.17566099 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.05517526 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.05208734 |
| 21 | MP0002736_abnormal_nociception_after | 2.01817522 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 1.97656378 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 1.90000274 |
| 24 | MP0001984_abnormal_olfaction | 1.82413661 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 1.81417017 |
| 26 | MP0004885_abnormal_endolymph | 1.73977214 |
| 27 | MP0002638_abnormal_pupillary_reflex | 1.69413855 |
| 28 | MP0006276_abnormal_autonomic_nervous | 1.69281864 |
| 29 | MP0001440_abnormal_grooming_behavior | 1.67476489 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.63633482 |
| 31 | MP0002067_abnormal_sensory_capabilities | 1.63124893 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.58993526 |
| 33 | MP0003122_maternal_imprinting | 1.58716821 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.58465075 |
| 35 | MP0004924_abnormal_behavior | 1.58465075 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.57945197 |
| 37 | MP0003195_calcinosis | 1.55227267 |
| 38 | MP0001970_abnormal_pain_threshold | 1.53868525 |
| 39 | MP0004142_abnormal_muscle_tone | 1.52193112 |
| 40 | MP0002928_abnormal_bile_duct | 1.49324672 |
| 41 | MP0001188_hyperpigmentation | 1.48691333 |
| 42 | MP0000778_abnormal_nervous_system | 1.47161301 |
| 43 | MP0001905_abnormal_dopamine_level | 1.46442325 |
| 44 | MP0001529_abnormal_vocalization | 1.44178376 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.43738299 |
| 46 | MP0003121_genomic_imprinting | 1.42151299 |
| 47 | MP0004811_abnormal_neuron_physiology | 1.41783523 |
| 48 | MP0003879_abnormal_hair_cell | 1.38931968 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.37786497 |
| 50 | MP0004043_abnormal_pH_regulation | 1.28743373 |
| 51 | MP0005499_abnormal_olfactory_system | 1.26652990 |
| 52 | MP0005394_taste/olfaction_phenotype | 1.26652990 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.24328443 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.22916237 |
| 55 | MP0005253_abnormal_eye_physiology | 1.22173137 |
| 56 | MP0002229_neurodegeneration | 1.20915599 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.14196880 |
| 58 | MP0002184_abnormal_innervation | 1.13109702 |
| 59 | MP0006072_abnormal_retinal_apoptosis | 1.10075211 |
| 60 | MP0001485_abnormal_pinna_reflex | 1.10008883 |
| 61 | MP0002066_abnormal_motor_capabilities/c | 1.09302280 |
| 62 | MP0000955_abnormal_spinal_cord | 1.09033771 |
| 63 | MP0008872_abnormal_physiological_respon | 1.06068391 |
| 64 | MP0008995_early_reproductive_senescence | 1.05643912 |
| 65 | MP0008789_abnormal_olfactory_epithelium | 1.03918839 |
| 66 | MP0002653_abnormal_ependyma_morphology | 1.02909543 |
| 67 | MP0003633_abnormal_nervous_system | 1.00671361 |
| 68 | MP0000631_abnormal_neuroendocrine_gland | 1.00310847 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 0.97576812 |
| 70 | MP0008569_lethality_at_weaning | 0.96827795 |
| 71 | MP0004215_abnormal_myocardial_fiber | 0.96763017 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.96661781 |
| 73 | MP0000427_abnormal_hair_cycle | 0.96470863 |
| 74 | MP0005535_abnormal_body_temperature | 0.93852010 |
| 75 | MP0001502_abnormal_circadian_rhythm | 0.93714264 |
| 76 | MP0002876_abnormal_thyroid_physiology | 0.92443393 |
| 77 | MP0002069_abnormal_eating/drinking_beha | 0.91962019 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 0.91062111 |
| 79 | MP0004133_heterotaxia | 0.89261028 |
| 80 | MP0003283_abnormal_digestive_organ | 0.87887031 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 0.86405353 |
| 82 | MP0004742_abnormal_vestibular_system | 0.85638981 |
| 83 | MP0002752_abnormal_somatic_nervous | 0.83355539 |
| 84 | MP0001963_abnormal_hearing_physiology | 0.83252165 |
| 85 | MP0002234_abnormal_pharynx_morphology | 0.82030364 |
| 86 | MP0003183_abnormal_peptide_metabolism | 0.81172126 |
| 87 | MP0003631_nervous_system_phenotype | 0.79183274 |
| 88 | MP0003698_abnormal_male_reproductive | 0.78238290 |
| 89 | MP0004147_increased_porphyrin_level | 0.75631600 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 0.75551266 |
| 91 | MP0004484_altered_response_of | 0.74234362 |
| 92 | MP0002152_abnormal_brain_morphology | 0.73778590 |
| 93 | MP0006292_abnormal_olfactory_placode | 0.73307235 |
| 94 | MP0004145_abnormal_muscle_electrophysio | 0.73129143 |
| 95 | MP0000026_abnormal_inner_ear | 0.71453322 |
| 96 | MP0005410_abnormal_fertilization | 0.69718505 |
| 97 | MP0002751_abnormal_autonomic_nervous | 0.67500259 |
| 98 | MP0002163_abnormal_gland_morphology | 0.65952897 |
| 99 | MP0002090_abnormal_vision | 0.65742101 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.65723794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.56081996 |
| 2 | Febrile seizures (HP:0002373) | 4.45449713 |
| 3 | Epileptic encephalopathy (HP:0200134) | 3.62949012 |
| 4 | Medial flaring of the eyebrow (HP:0010747) | 3.60433370 |
| 5 | Atonic seizures (HP:0010819) | 3.45792547 |
| 6 | Hyperventilation (HP:0002883) | 3.44391751 |
| 7 | Gait imbalance (HP:0002141) | 3.41236085 |
| 8 | Focal seizures (HP:0007359) | 3.34418372 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 3.34218891 |
| 10 | Congenital primary aphakia (HP:0007707) | 3.08513588 |
| 11 | Hemiparesis (HP:0001269) | 3.05628988 |
| 12 | Type II lissencephaly (HP:0007260) | 3.04851098 |
| 13 | Lissencephaly (HP:0001339) | 3.01813433 |
| 14 | Nephrogenic diabetes insipidus (HP:0009806) | 2.97582056 |
| 15 | Genetic anticipation (HP:0003743) | 2.96836470 |
| 16 | Pancreatic fibrosis (HP:0100732) | 2.94076373 |
| 17 | Progressive inability to walk (HP:0002505) | 2.91192290 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 2.90055322 |
| 19 | Epileptiform EEG discharges (HP:0011182) | 2.88564563 |
| 20 | Myokymia (HP:0002411) | 2.87652186 |
| 21 | Hypsarrhythmia (HP:0002521) | 2.86798596 |
| 22 | EEG with generalized epileptiform discharges (HP:0011198) | 2.86654090 |
| 23 | Dialeptic seizures (HP:0011146) | 2.86257397 |
| 24 | Nephronophthisis (HP:0000090) | 2.80779088 |
| 25 | Absent speech (HP:0001344) | 2.78700338 |
| 26 | Pancreatic cysts (HP:0001737) | 2.78641370 |
| 27 | Abnormality of the renal cortex (HP:0011035) | 2.66361589 |
| 28 | Absence seizures (HP:0002121) | 2.66349117 |
| 29 | Genital tract atresia (HP:0001827) | 2.63909156 |
| 30 | Urinary urgency (HP:0000012) | 2.63804445 |
| 31 | Ankle clonus (HP:0011448) | 2.59751276 |
| 32 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.58714037 |
| 33 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.58714037 |
| 34 | Congenital stationary night blindness (HP:0007642) | 2.56933605 |
| 35 | Molar tooth sign on MRI (HP:0002419) | 2.56278462 |
| 36 | Abnormality of midbrain morphology (HP:0002418) | 2.56278462 |
| 37 | Anterior segment dysgenesis (HP:0007700) | 2.54342049 |
| 38 | Spastic gait (HP:0002064) | 2.50166890 |
| 39 | Postural instability (HP:0002172) | 2.50028126 |
| 40 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.49147427 |
| 41 | Generalized tonic-clonic seizures (HP:0002069) | 2.48918521 |
| 42 | Limb dystonia (HP:0002451) | 2.46870791 |
| 43 | True hermaphroditism (HP:0010459) | 2.46466715 |
| 44 | Renal cortical cysts (HP:0000803) | 2.46220536 |
| 45 | Inability to walk (HP:0002540) | 2.46186607 |
| 46 | Abnormality of the renal medulla (HP:0100957) | 2.44274366 |
| 47 | Retinal dysplasia (HP:0007973) | 2.43979630 |
| 48 | Polyphagia (HP:0002591) | 2.40913788 |
| 49 | Vaginal atresia (HP:0000148) | 2.39488322 |
| 50 | Broad-based gait (HP:0002136) | 2.38322637 |
| 51 | Pachygyria (HP:0001302) | 2.38081157 |
| 52 | Protruding tongue (HP:0010808) | 2.35784532 |
| 53 | Abnormal drinking behavior (HP:0030082) | 2.33330821 |
| 54 | Polydipsia (HP:0001959) | 2.33330821 |
| 55 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.32011249 |
| 56 | Hypoplasia of the fovea (HP:0007750) | 2.32011249 |
| 57 | Hypothermia (HP:0002045) | 2.28545647 |
| 58 | Amyotrophic lateral sclerosis (HP:0007354) | 2.27427461 |
| 59 | Status epilepticus (HP:0002133) | 2.26510917 |
| 60 | Drooling (HP:0002307) | 2.25853327 |
| 61 | Lower limb muscle weakness (HP:0007340) | 2.24831545 |
| 62 | Abnormality of the corticospinal tract (HP:0002492) | 2.24737089 |
| 63 | Action tremor (HP:0002345) | 2.18264588 |
| 64 | Ketoacidosis (HP:0001993) | 2.17859905 |
| 65 | Dyskinesia (HP:0100660) | 2.13563082 |
| 66 | Chronic hepatic failure (HP:0100626) | 2.10285902 |
| 67 | Excessive salivation (HP:0003781) | 2.09387004 |
| 68 | Abnormality of the labia minora (HP:0012880) | 2.08524856 |
| 69 | Spastic tetraplegia (HP:0002510) | 2.06803948 |
| 70 | Abnormal eating behavior (HP:0100738) | 2.03395266 |
| 71 | Specific learning disability (HP:0001328) | 2.01672049 |
| 72 | Poor eye contact (HP:0000817) | 2.01103563 |
| 73 | Muscular hypotonia of the trunk (HP:0008936) | 1.97980781 |
| 74 | Large for gestational age (HP:0001520) | 1.97460830 |
| 75 | Poor coordination (HP:0002370) | 1.96302597 |
| 76 | Agitation (HP:0000713) | 1.93304049 |
| 77 | Supranuclear gaze palsy (HP:0000605) | 1.92456063 |
| 78 | Severe muscular hypotonia (HP:0006829) | 1.90538456 |
| 79 | Intention tremor (HP:0002080) | 1.87929314 |
| 80 | Generalized myoclonic seizures (HP:0002123) | 1.87753385 |
| 81 | Optic nerve hypoplasia (HP:0000609) | 1.86977170 |
| 82 | Hip dysplasia (HP:0001385) | 1.86548526 |
| 83 | Abnormality of the fovea (HP:0000493) | 1.85217582 |
| 84 | Amblyopia (HP:0000646) | 1.84880506 |
| 85 | Increased circulating renin level (HP:0000848) | 1.83318506 |
| 86 | Polyuria (HP:0000103) | 1.82322677 |
| 87 | Esotropia (HP:0000565) | 1.77771018 |
| 88 | Widely spaced teeth (HP:0000687) | 1.77384843 |
| 89 | Failure to thrive in infancy (HP:0001531) | 1.75425336 |
| 90 | Ketosis (HP:0001946) | 1.75406688 |
| 91 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.74746150 |
| 92 | Fetal akinesia sequence (HP:0001989) | 1.73339391 |
| 93 | Postaxial hand polydactyly (HP:0001162) | 1.73315493 |
| 94 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.72632690 |
| 95 | Hypoplasia of the brainstem (HP:0002365) | 1.72632690 |
| 96 | Hypoglycemic coma (HP:0001325) | 1.71836354 |
| 97 | Dysdiadochokinesis (HP:0002075) | 1.71617994 |
| 98 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.71100384 |
| 99 | Hypomagnesemia (HP:0002917) | 1.70714283 |
| 100 | Paraplegia (HP:0010550) | 1.69891105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 5.45896550 |
| 2 | MARK1 | 3.68065169 |
| 3 | MAP3K4 | 3.61482298 |
| 4 | CASK | 3.31558633 |
| 5 | MAP4K2 | 3.24809389 |
| 6 | FRK | 3.17736376 |
| 7 | MAP2K7 | 2.80556400 |
| 8 | MAPK13 | 2.37989901 |
| 9 | BCR | 2.33801659 |
| 10 | EPHA4 | 2.28313355 |
| 11 | NTRK3 | 2.14583757 |
| 12 | WNK3 | 1.95358764 |
| 13 | DAPK2 | 1.95105514 |
| 14 | TRIM28 | 1.94221317 |
| 15 | MAP2K4 | 1.76548954 |
| 16 | NTRK2 | 1.66937156 |
| 17 | ADRBK2 | 1.63080125 |
| 18 | CDK19 | 1.50308053 |
| 19 | ERBB3 | 1.48188178 |
| 20 | PAK3 | 1.48133104 |
| 21 | PRKCG | 1.38812328 |
| 22 | SIK2 | 1.38378161 |
| 23 | CAMKK2 | 1.28280303 |
| 24 | TAOK3 | 1.24080468 |
| 25 | DYRK2 | 1.23442177 |
| 26 | MINK1 | 1.23350033 |
| 27 | UHMK1 | 1.19908394 |
| 28 | OXSR1 | 1.18300818 |
| 29 | BRD4 | 1.16971948 |
| 30 | PRKCE | 1.16808857 |
| 31 | GRK1 | 1.16075821 |
| 32 | CSNK1G2 | 1.15604770 |
| 33 | DYRK1A | 1.11668884 |
| 34 | INSRR | 1.11459137 |
| 35 | PLK2 | 1.11392096 |
| 36 | CDK5 | 1.07391184 |
| 37 | PHKG2 | 1.05529281 |
| 38 | PHKG1 | 1.05529281 |
| 39 | BMPR1B | 1.02368970 |
| 40 | PAK6 | 0.94249365 |
| 41 | CSNK1G3 | 0.93969778 |
| 42 | CSNK1A1L | 0.90801652 |
| 43 | MAP2K6 | 0.89601138 |
| 44 | CAMK2A | 0.88000036 |
| 45 | SGK494 | 0.85462211 |
| 46 | SGK223 | 0.85462211 |
| 47 | SGK2 | 0.83625050 |
| 48 | AKT3 | 0.82072334 |
| 49 | CSNK1G1 | 0.79867965 |
| 50 | KSR1 | 0.77320485 |
| 51 | STK38 | 0.76577322 |
| 52 | PIK3CA | 0.75730873 |
| 53 | FER | 0.74064102 |
| 54 | ACVR1B | 0.73838091 |
| 55 | MAP3K9 | 0.72185281 |
| 56 | ADRBK1 | 0.68438962 |
| 57 | PTK2B | 0.67957480 |
| 58 | BCKDK | 0.66973026 |
| 59 | STK38L | 0.66571566 |
| 60 | PRKCZ | 0.66110598 |
| 61 | CAMKK1 | 0.62790226 |
| 62 | MAP3K6 | 0.62230068 |
| 63 | CAMK1 | 0.61217545 |
| 64 | CAMK4 | 0.60194936 |
| 65 | SIK3 | 0.57817220 |
| 66 | NUAK1 | 0.56266193 |
| 67 | STK11 | 0.56181549 |
| 68 | GRK5 | 0.55136863 |
| 69 | FGFR2 | 0.54991288 |
| 70 | NEK6 | 0.53837627 |
| 71 | MAP3K5 | 0.53815090 |
| 72 | CAMK2B | 0.53519117 |
| 73 | RPS6KA4 | 0.53142181 |
| 74 | PNCK | 0.52129037 |
| 75 | PRKACA | 0.49893500 |
| 76 | TAOK1 | 0.48305238 |
| 77 | PRKAA1 | 0.46902899 |
| 78 | CDK14 | 0.44974972 |
| 79 | FLT3 | 0.44509283 |
| 80 | PASK | 0.42569625 |
| 81 | CSNK1A1 | 0.42527505 |
| 82 | SGK1 | 0.42264355 |
| 83 | PKN1 | 0.40848232 |
| 84 | CDK18 | 0.40631104 |
| 85 | MAP3K12 | 0.39946898 |
| 86 | EPHA3 | 0.38983835 |
| 87 | CAMK2D | 0.36725204 |
| 88 | MUSK | 0.35341507 |
| 89 | WNK4 | 0.35322582 |
| 90 | CDK3 | 0.34912895 |
| 91 | ABL1 | 0.33647440 |
| 92 | MAP3K7 | 0.33610756 |
| 93 | STK39 | 0.33490149 |
| 94 | DAPK1 | 0.33222462 |
| 95 | CDK15 | 0.33214469 |
| 96 | TNIK | 0.32376296 |
| 97 | PRKCH | 0.31912545 |
| 98 | RPS6KA3 | 0.31720173 |
| 99 | ZAK | 0.31581290 |
| 100 | RPS6KA5 | 0.31568988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.66377301 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.54056968 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 3.14435999 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 3.00698549 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.86499776 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.66228936 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.55492368 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.44523428 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.26298861 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.13083063 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.09828280 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.01870194 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.94725750 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.92146480 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.91510296 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.83686364 |
| 17 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.81735059 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.79428957 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.66473880 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.62217340 |
| 21 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.61945822 |
| 22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.58180046 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.43904441 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.42956697 |
| 25 | Olfactory transduction_Homo sapiens_hsa04740 | 1.42221810 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.30072173 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.28907938 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.28797266 |
| 29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.27895792 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.26351532 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.25969930 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.20050917 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.19970516 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.19946473 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.18250430 |
| 36 | Circadian rhythm_Homo sapiens_hsa04710 | 1.13817358 |
| 37 | Basal transcription factors_Homo sapiens_hsa03022 | 1.11683281 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.08572941 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08088855 |
| 40 | Renin secretion_Homo sapiens_hsa04924 | 1.05215799 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.04370016 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97269291 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.96651470 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.96454714 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93233104 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90502848 |
| 47 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89885687 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89793552 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.84468786 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84273153 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 0.78373996 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 0.78366534 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78011681 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 0.75099308 |
| 55 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74792184 |
| 56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70309932 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67909826 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67145073 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64125848 |
| 60 | Axon guidance_Homo sapiens_hsa04360 | 0.60963870 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60638659 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59399212 |
| 63 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57717111 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57060183 |
| 65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.56973514 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54792376 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53703437 |
| 68 | RNA degradation_Homo sapiens_hsa03018 | 0.53497908 |
| 69 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53202005 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52861447 |
| 71 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52382510 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52139220 |
| 73 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51799690 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50078128 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46965379 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46779886 |
| 77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45834275 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45826260 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45319162 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43930280 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42459001 |
| 82 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41806346 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41483028 |
| 84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39310658 |
| 85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.35955500 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34239601 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34094733 |
| 88 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.33807750 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33405492 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32245786 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30541689 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29944554 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27575652 |
| 94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.24862215 |
| 95 | RNA polymerase_Homo sapiens_hsa03020 | 0.23924010 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23072856 |
| 97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.22015060 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20371694 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.20036348 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19956442 |

